Cytiva_Jan2022_mRNAVaccinesANewEra - 9

mRNA VACCINES: A NEW ERA OF BIOTHERAPEUTIC DEVELOPMENT
agencies will be paramount to support these
endeavors. It is clear that investment in these
innovations is needed to ensure preparedness in
the event of future outbreaks and pandemics.
Precision NanoSystems is leveraging years
of experience in LNP formulation, vaccine
manufacturing platform development, and
industry know-how to usher in the new
frontier of vaccine production. Through the
company's active involvement in the novel
COVID-19 mRNA vaccines, this specialized
knowledge and expertise, paired with highly
scalable instrument platforms and LNP
reagents, can be leveraged by researchers,
developers, and manufacturers alike. n
References
1. The Independent Panel for Pandemic Preparedness
and Response. COVID-19: Make It the Last Pandemic.
https://theindependentpanel.org/wp-content/
uploads/2021/05/COVID-19-Make-it-the-LastPandemic_final.pdf.
Published: May 12, 2021. Accessed:
November 5, 2021.
2. Bloom DE, Cadarette D, Ferranna M, Hyer RN, Tortorice
DL. How New Models Of Vaccine Development For
COVID-19 Have Helped Address An Epic Public Health
Crisis. Health Aff. (Millwood). 2021; 40(3): 410-418. DOI:
10.1377/hlthaff.2020.02012.
3. Ball P. The lightning-fast quest for COVID vaccines-
and what it means for other diseases. Nature 2021;
589(7840): 16-18. DOI: 10.1038/d41586-020-03626-1.
4. Dolgin E. The tangled history of mRNA vaccines. Nature
2021; 597(7876): 318-324. DOI: 10.1038/d41586-02102483-w.
5.
Kis Z, Kontoravdi C, Dey AK, Shattock R, Shah N. Rapid
development and deployment of high-volume vaccines
for pandemic response. J. Adv. Manuf. Process. 2020;
2(3): e10060. DOI: 10.1002/amp2.10060.
6. Sell TK, Gastfriend D, Watson M, et al. Building the global
vaccine manufacturing capacity needed to respond to
pandemics. Vaccine 2021; 39(12): 1667-1669. DOI:
10.1016/j.vaccine.2021.02.017.
7. Freemont P, Curach N, Friedman D, Lee SY. These
'biofoundries' use DNA to make natural products we
need. World Economic Forum. https://www.weforum.
org/agenda/2019/10/biofoundries-the-new-factoriesfor-genetic-products/.
Published October 28, 2019.
Accessed: October 20, 2021.
8. R3: RNA Readiness & Response Program. Wellcome
Leap. https://wellcomeleap.org/r3. Published July 14,
2020. Accessed November 5, 2021.
Additional Resources...
Videos and Webinars
Learn how Precision NanoSystems
can help accelerate development
of genomic medicines.
Watch Here
GENengnews.com | 9

https://www.cytivalifesciences.com/en/us https://theindependentpanel.org/wp-content/uploads/2021/05/COVID-19-Make-it-the-Last-Pandemic_final.pdf https://www.weforum.org/agenda/2019/10/biofoundries-the-new-factories-for-genetic-products/ https://www.weforum.org/agenda/2019/10/biofoundries-the-new-factories-for-genetic-products/ https://www.weforum.org/agenda/2019/10/biofoundries-the-new-factories-for-genetic-products/ https://theindependentpanel.org/wp-content/uploads/2021/05/COVID-19-Make-it-the-Last-Pandemic_final.pdf https://www.wellcomeleap.org/r3 https://theindependentpanel.org/wp-content/uploads/2021/05/COVID-19-Make-it-the-Last-Pandemic_final.pdf https://www.precisionnanosystems.com/resources-and-community/resource-center/webinars-videos https://www.precisionnanosystems.com https://www.genengnews.com

Cytiva_Jan2022_mRNAVaccinesANewEra

Table of Contents for the Digital Edition of Cytiva_Jan2022_mRNAVaccinesANewEra